Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.7M
-1.5% from 2023
Prescriptions
3,244
$11,935.87 per claim
Patients
1,499
924 prescribers
Total spending, 2024
$38.7M
$25,830.53 per patient
Medicare prescription drug plans paid $38.7M for Rituxan in 2024, for 3,244 prescriptions and refills to 1,499 patients (down 1.5% from 2023). The average cost per claim was $11,935.87.
California had the highest Medicare cost for Rituxan in 2024: $9.1M for 788 claims, followed by Texas ($5.7M).
Elvin R Garcia, rheumatology in McAllen, TX, had the highest Medicare cost for Rituxan in 2024: 115 claims costing $2.0M.
Rituxan is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Elvin R Garcia McAllen, TX | Rheumatology | 115 | 58 | $2.0M |
| Srikanth Naramala Visalia, CA | Rheumatology | 54 | 36 | $658K |
| Swetha S Yadav Kearney, NE |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 888 | 3,638 | 1,535 | $46.0M |
| 2023 | 871 | 3,157 | 1,425 | $39.3M |
| 2024 | 924 | 3,244 | 1,499 | $38.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 31 |
| Under 11 |
| $546K |
| Babak Zamiri Riverside, CA | Rheumatology | 32 | 18 | $533K |
| Sergei Grando Irvine, CA | Dermatology | 77 | 12 | $464K |
| Jennifer M Lynch Hartsville, SC | Nurse Practitioner | 26 | 12 | $445K |
| Rahul R Naik Los Angeles, CA | Hematology-Oncology | 17 | Under 11 | $349K |
| Geeta E George Peekskill, NY | Hematology-Oncology | 24 | Under 11 | $328K |
| Cosmin Dascalu Babylon, NY | Rheumatology | 18 | Under 11 | $319K |
| Kavita B Kalra Baltimore, MD | Hematology-Oncology | 26 | 13 | $312K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 24 | 12 | $309K |
| Ann M Wierman Las Vegas, NV | Hematology-Oncology | 44 | Under 11 | $275K |
| Naiara Alvarez Harlingen, TX | Rheumatology | 18 | 13 | $270K |
| Hayman S Salib Easton, PA | Hematology-Oncology | 17 | Under 11 | $250K |
| Joo-Hyung Lee Orange, CA | Rheumatology | 14 | Under 11 | $241K |
| Paul M Swanson Port St Lucie, FL | Hematology-Oncology | 13 | Under 11 | $237K |
| Guillermo J Valenzuela Plantation, FL | Rheumatology | 16 | Under 11 | $233K |
| Sarena Kelly Bridgeport, CT | Nurse Practitioner | 11 | Under 11 | $215K |
| Bruce S Stein Floral Park, NY | Internal Medicine | 12 | Under 11 | $210K |
| Danny R Bartel Wichita Falls, TX | Neurology | 15 | Under 11 | $194K |
| Samy K Metyas Covina, CA | Rheumatology | 11 | Under 11 | $193K |
| Nazanin Firooz Woodland Hills, CA | Rheumatology | 13 | Under 11 | $186K |
| Richard E Jones III Northport, AL | Rheumatology | 19 | Under 11 | $183K |
| Charles Famoyin Johnson City, TN | General Practice | 21 | Under 11 | $180K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 18 | Under 11 | $170K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 3,244 | $38.7M |